4D Molecular Therapeutics FDMT Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares MQ Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates DNUT Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh on Performance MPLX Q1 2026 Earnings EPS Misses Estimates by 156 as Midstream Operations Face Headwinds SSYS Q1 2026 Earnings Narrower Loss Surprises Market Shares Rally ABEO Q1 2026 Earnings NarrowerthanExpected Loss Bolstered by Cost Management